Activation of the nuclear transcription factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway significantly attenuates oxygen-glucose deprivation (OGD)-induced damage in human neuroblastoma cells. This evidence concerns the gene HMOX1 and neuroblastoma.